Latest / The Trauma Therapist / Mindbloom is Helping Us Heal with Mike Petegorsky
Transcript
- 0:00Speaker 1: Trauma Thepist Podcast Plus listeners can listen to episodes early
- 0:03Speaker 1: and ad free right now. Become a Plus listener by
- 0:07Speaker 1: going to Apple Podcasts searching for the Trauma Thepist podcast
- 0:11Speaker 1: and signing up today. Welcome to the Trauma Nevers Podcast,
- 0:18Speaker 1: a show about the incredible people dedicated to helping those
- 0:21Speaker 1: who experienced trauma. My name is Got macpherson, and my
- 0:24Speaker 1: mission is to raise awareness of trauma and to inspire
- 0:27Speaker 1: each of us to help those around us. All right,
- 0:38Speaker 1: five four, three, two and one, our folks, welcome back
- 0:42Speaker 1: to the podcast. Very excited to hap us. Mike guest today,
- 0:46Speaker 1: Mike Pettigworski. Mike, welcome, Thank you so much.
- 0:49Speaker 2: Guy.
- 0:49Speaker 3: It's really a pleasure to be here with you.
- 0:51Speaker 2: Awesome.
- 0:52Speaker 1: So. Mike is the chief Strategy Officer of mind Bloom,
- 0:55Speaker 1: the largest provider of psychedelic therapy. Mind Bloom is the
- 0:59Speaker 1: first and largest national provider of psychedelic therapy. They facilitated
- 1:04Speaker 1: over five hundred thousand at home Kedeman therapy sessions in
- 1:07Speaker 1: thirty eight states. Their mission is to make at home
- 1:10Speaker 1: Kedemin therapy a mainstream mental health treatment for everybody. Mike
- 1:14Speaker 1: is passionate about creating my Bloom's legacy as the most
- 1:17Speaker 1: trusted name in psychedelics. LL Mike before we get in here,
- 1:22Speaker 1: before we dive in, and I know you're ready, share
- 1:27Speaker 1: with the listeners where you're from originally and where you
- 1:29Speaker 1: are currently.
- 1:30Speaker 3: Yeah. I'm from a small town called Northampton, Massachusetts.
- 1:34Speaker 4: It's in western mass about two hours west of Boston,
- 1:36Speaker 4: but before you hit the Berkshire's if you're driving.
- 1:39Speaker 3: East to west.
- 1:41Speaker 4: I went to college in Philly, spent a decade in
- 1:43Speaker 4: New York City, and have been in Austin, Texas for
- 1:45Speaker 4: the past three years.
- 1:47Speaker 2: And cool.
- 1:48Speaker 3: Yeah, Yeah.
- 1:49Speaker 4: It was really a big transition that happened around COVID
- 1:55Speaker 4: where I had been a big law firm, lawyer in
- 1:59Speaker 4: one of those international firms with a thousand lawyers, you know,
- 2:02Speaker 4: midtown skyscraper kind of like that shows suits, and I
- 2:07Speaker 4: thought that was where life was headed. And a mixture
- 2:11Speaker 4: of psychedelic medicine and really kind of taking my life
- 2:18Speaker 4: more seriously than maybe I had in the past caused
- 2:20Speaker 4: me to rethink all that left big law, left New York,
- 2:23Speaker 4: came to mind Bloom to help advance psychedelic therapy, and
- 2:26Speaker 4: came out to Austin to build a family.
- 2:29Speaker 1: Okay, that's that's the thumbnail. Let's let's go back. First
- 2:34Speaker 1: of all, you're hitting a lot of great places in
- 2:35Speaker 1: the States. I know, Northampton very coz.
- 2:39Speaker 2: Yeah. Where'd you go school in Philly?
- 2:41Speaker 3: I was at Penn University of Pennsylvania.
- 2:43Speaker 2: Okay, awesome, So did were you?
- 2:49Speaker 1: Well?
- 2:49Speaker 2: You must have been.
- 2:50Speaker 1: You must have been in that pipeline getting into law. Right,
- 2:54Speaker 1: this is where I'm going Penn and everything.
- 2:56Speaker 3: Talk a little bit about exactly right. That's exactly right.
- 2:59Speaker 4: You know, growing up in a kind of hippie town,
- 3:01Speaker 4: I think most timelines for me would have led to
- 3:05Speaker 4: political organizing or teaching or something more kind of liberal arts,
- 3:11Speaker 4: more human focused in some ways. And when I was
- 3:16Speaker 4: a plan of college, so I got into Penn and
- 3:19Speaker 4: it was the best school on my list, and I
- 3:20Speaker 4: was excited to go there.
- 3:21Speaker 3: So I went.
- 3:22Speaker 4: And Penn is a school where most people go into finance,
- 3:25Speaker 4: and there's really this kind of business world focus and
- 3:29Speaker 4: intense pressure on joining kind of that corporate ladder world,
- 3:32Speaker 4: whether it's consulting or investment, banking or law or something else.
- 3:36Speaker 4: I never found finance interesting, but law seemed at the
- 3:41Speaker 4: time like a way to do something intellectually stimulating and
- 3:44Speaker 4: challenging and help people along the way.
- 3:46Speaker 3: And I had visions of.
- 3:48Speaker 4: Being an environmental lawyer or doing other things that really
- 3:52Speaker 4: served the world and the people. But then you get
- 3:54Speaker 4: to law school and these big firms come for recruiting
- 3:56Speaker 4: and they tell you that first year salary and you say, oh, well,
- 4:01Speaker 4: that's interesting, right.
- 4:03Speaker 2: Right, and climate what climate? Yeah?
- 4:06Speaker 4: Yeah, And so then you tell yourself a story that
- 4:10Speaker 4: you'll make some money, set it aside, do that work,
- 4:13Speaker 4: get the experience, and then eventually you'll go do that
- 4:15Speaker 4: good thing somewhere else, right, And then you start doing it,
- 4:20Speaker 4: and you know, they raise the salary every year. They
- 4:22Speaker 4: always kind of dangle the carrot a little farther, and
- 4:24Speaker 4: so you just keep going. And so what I was
- 4:26Speaker 4: doing was patent litigation. I represented Fortune fifty companies in
- 4:31Speaker 4: patent cases around high tech stuff, whether it's dental nanocomposits
- 4:35Speaker 4: or shielded electrical ribbon cables or antibodies.
- 4:39Speaker 3: And it's fun, but it was like gladiators for nerds.
- 4:42Speaker 4: You know, it's really hard, it's really intense, and I'm
- 4:44Speaker 4: a big nerd, so I like to argue about what
- 4:46Speaker 4: words mean, or how the technology works. But eventually you
- 4:49Speaker 4: just realize, holy cow, this isn't really helping people. This
- 4:54Speaker 4: is moving money around for some big corporations. And at
- 4:57Speaker 4: the end of the day, I don't know that anyone's
- 4:59Speaker 4: lives were made any better.
- 5:00Speaker 3: By doing it.
- 5:00Speaker 1: And so, well, mean, for a second, that's that's a
- 5:03Speaker 1: big realization, right, I mean, it's it's a simple realization,
- 5:09Speaker 1: but it's huge.
- 5:10Speaker 2: How did you get to there?
- 5:13Speaker 4: Yeah, I mean I think for me, the realization was
- 5:15Speaker 4: at a certain point, you can either have work. Is
- 5:21Speaker 4: this really interesting concept in this country. You know, it's
- 5:24Speaker 4: a means to an end and that it lets you
- 5:27Speaker 4: have a house, in food and maybe enjoy yourself, but
- 5:29Speaker 4: it also is really a source of meaning for a
- 5:31Speaker 4: lot of people. And I realized, like, you can either
- 5:34Speaker 4: do work that gives you meaning or work that enables
- 5:39Speaker 4: you to do other things that give you meaning, and
- 5:41Speaker 4: that's kind of the means to an end there. And
- 5:43Speaker 4: I actually realized I was over too. I was working
- 5:46Speaker 4: so much I didn't have time to do anything else,
- 5:48Speaker 4: and it actually didn't give me meaning to help a
- 5:50Speaker 4: big fortune fifty company save a few million or one
- 5:53Speaker 4: hundred million or a billion dollars, so just I didn't
- 5:55Speaker 4: I didn't care. And the way I was able to
- 5:59Speaker 4: get there was actually through psychedelics. And this is obviously
- 6:05Speaker 4: before I worked at mind Bloom. I you know, I
- 6:07Speaker 4: had been a mind Bloom client actually before I worked
- 6:10Speaker 4: here and got Ketymine therapy, and I had used other
- 6:12Speaker 4: psychedelic medicines as well, and they helped me get this perspective,
- 6:17Speaker 4: you know, I think, and I'm sure you've kind of
- 6:20Speaker 4: experienced this. Most of us live, our lives right here
- 6:24Speaker 4: where it's right in front of our eyes, and our
- 6:26Speaker 4: whole existence is right.
- 6:27Speaker 3: At that level where the world meets your eyes.
- 6:29Speaker 4: And then psychedelics let you step back a little bit
- 6:31Speaker 4: or get a bird's eye view, a different perspective on it.
- 6:34Speaker 3: And you see these ways in which you.
- 6:36Speaker 4: Move about your job, move about the world kind of
- 6:38Speaker 4: following some script or pattern, and you say, when's the
- 6:41Speaker 4: fun part, when's the meaning, when's the value, When's.
- 6:44Speaker 3: The part where I'm really gonna do something that helps people?
- 6:47Speaker 3: And that was.
- 6:49Speaker 4: Really Psychedelic medicine was really what let me realize that
- 6:52Speaker 4: I was on a path to nowhere.
- 6:55Speaker 2: Excuse me? What led you to psychedelix in the first place.
- 7:02Speaker 4: Well, I had struggled with anxiety for my whole life,
- 7:06Speaker 4: and it was something it was mostly in a social context.
- 7:14Speaker 4: I mean, so the short answer question was other things
- 7:17Speaker 4: didn't help me and I needed to try something new.
- 7:19Speaker 4: The longer story is, I startled with social anxiety really
- 7:23Speaker 4: kind of as far back as I can remember. I mean,
- 7:26Speaker 4: it's this is kind of sound kind of odd that
- 7:28Speaker 4: it started with sweating.
- 7:29Speaker 3: I would get sweaty. I was made fun of. You know,
- 7:32Speaker 3: trauma is a word that I.
- 7:34Speaker 4: Try to use carefully because I think, you know, I'm
- 7:36Speaker 4: not a clinician, I'm not a mental health provider, and
- 7:38Speaker 4: I think it has you know, it has real meaning.
- 7:41Speaker 4: But after a certain amount of kind of ridicule by
- 7:44Speaker 4: my peers and other things, I internalized some of that,
- 7:47Speaker 4: and I internalized some broader social anxiety. And I cannot
- 7:51Speaker 4: tell you, guy, how many times I walked out of prom,
- 7:56Speaker 4: my high school, graduation, later, job interview meetings, dates because
- 8:01Speaker 4: I would get this fight or flight response, this intense panic.
- 8:04Speaker 3: My chest would seize up.
- 8:05Speaker 4: It was basically a panic attack, usually triggered by sweating
- 8:09Speaker 4: or heat, or that some discomfort in a physically because you.
- 8:11Speaker 1: Felt you were sweating too much, and oh my god,
- 8:13Speaker 1: I don't want to sweat too much in these pop
- 8:15Speaker 1: I'm gonna.
- 8:15Speaker 4: Get too I will be projected and I will be
- 8:19Speaker 4: gross whatever it is, right ye. And I was otherwise
- 8:22Speaker 4: a really social guid and like a lot of people do,
- 8:24Speaker 4: I compensated by building up a lot of social skills
- 8:28Speaker 4: to try to hide.
- 8:29Speaker 3: That or get around that.
- 8:30Speaker 4: But it never went away, and as it got worse
- 8:33Speaker 4: as I got older, I was medicating with klonapin, with
- 8:36Speaker 4: beta blockers. I tried psychotherapy. Nothing really worked over the
- 8:41Speaker 4: long term, but the pills did in acute settings. So
- 8:44Speaker 4: I could take clonapin and beta blockers and get through something,
- 8:48Speaker 4: but it would wipe my memory. And so I had
- 8:51Speaker 4: this real devil's bargain where I said, Okay, I can
- 8:53Speaker 4: get through this event. I know I'll get through, but
- 8:56Speaker 4: I won't remember it later and it's horrible, And so,
- 9:01Speaker 4: you know, I had that struggle. I was introduced to
- 9:06Speaker 4: psychedelics actually in college in kind of a recreational setting,
- 9:09Speaker 4: and it was, you know, plant medicine, and it stunned
- 9:14Speaker 4: me because it showed me a sense of self compassion,
- 9:19Speaker 4: self love, self acceptance that I had never felt before,
- 9:23Speaker 4: and I said, this is different, This has real power.
- 9:27Speaker 4: And I started researching and oh my god, there were
- 9:30Speaker 4: decades of studies showing that these things could really transform
- 9:33Speaker 4: me mental health, but they.
- 9:34Speaker 3: Were locked up. They were locked on the shelf because
- 9:36Speaker 3: of crazy regulation. And the founder of mind Bloom actually
- 9:40Speaker 3: is one of my best friends from college, going back
- 9:42Speaker 3: to my freshman year, and he started this company. He
- 9:44Speaker 3: told me what he was doing, and I said, as
- 9:46Speaker 3: a lawyer, a lot of people are going to call
- 9:49Speaker 3: you crazy. I think there's a way to do this.
- 9:50Speaker 4: Most psychedelics are legal, but I think there's a way
- 9:52Speaker 4: you can with ketamine therapy. And as he started building
- 9:56Speaker 4: this and psychedelics, including mind Bloom, unlocked more from me,
- 10:00Speaker 4: said I have to go join this.
- 10:01Speaker 3: I have to go help.
- 10:02Speaker 4: I have to bring this to other people and give
- 10:04Speaker 4: them this thing that helped me so much.
- 10:10Speaker 1: Talk a little bit more about and when we say
- 10:13Speaker 1: it helped you, what are we talking about specifically that
- 10:15Speaker 1: helps you?
- 10:16Speaker 4: I guess really in the end, it was ketemine therapy,
- 10:18Speaker 4: and I can I mean, I I'll tell you about
- 10:21Speaker 4: my experience with it because it was so profound, and
- 10:24Speaker 4: I think a lot of people wonder like, what's it?
- 10:26Speaker 3: Like, what can I actually for?
- 10:28Speaker 2: First of all, what is ketamine?
- 10:29Speaker 4: For those who are listening, Ketamine is a medicine. It's
- 10:35Speaker 4: made in a lab and it is Historically it's been
- 10:38Speaker 4: considered a dissociative anesthetic, and what that means is that
- 10:42Speaker 4: it has both physical effects. It kind of can block
- 10:44Speaker 4: or suppress physical pain in really high doses. It can
- 10:47Speaker 4: siderate you kind of help you go to sleep, but
- 10:50Speaker 4: it also causes dissociation, which is a sense of separation
- 10:54Speaker 4: from your normal thoughts or feelings. It's like you're still
- 10:57Speaker 4: conscious in viewing the world, but you're not through the
- 10:59Speaker 4: viewing them through your own eyes. It's like you borrowed
- 11:01Speaker 4: a pair of objective eyes that don't have a person
- 11:03Speaker 4: behind them, and you just get to see the world
- 11:06Speaker 4: not through the lens of all your past experiences and memories,
- 11:08Speaker 4: but just like what is And it was synthesized first
- 11:14Speaker 4: and approved by the FDA in nineteen seventy for use
- 11:17Speaker 4: as an anesthetic, and so it's actually been on the
- 11:20Speaker 4: World Health Organization's list of Essential medicine since nineteen eighty five.
- 11:23Speaker 4: It's in almost every ambulance you see driving down the street.
- 11:26Speaker 4: It's in dental offices and surgery rooms to help people
- 11:30Speaker 4: with medical procedures. But after decades of use, doctors started
- 11:36Speaker 4: noticing some patients who got ketamine for medical procedures started
- 11:42Speaker 4: reporting that they felt better mentally afterwards, that depression lifted,
- 11:46Speaker 4: that anxiety lifted, and doctor said, what's going on. And
- 11:49Speaker 4: it wasn't until two thousand that the first study was
- 11:51Speaker 4: published actually showing in a randomized controlled trial that ketamine
- 11:56Speaker 4: is incredibly effective in treating depression. And what's from remark
- 12:00Speaker 4: a little about it is not just how effective it is,
- 12:02Speaker 4: but how fast acting it is. A lot of the
- 12:04Speaker 4: studies are showing significant improvements in hours or days after treatment,
- 12:09Speaker 4: whereas other antidepressant drugs can take weeks or months to
- 12:13Speaker 4: start working. And so in two thousand you had that first,
- 12:16Speaker 4: you know, ironclad scientific study by professors and researchers at Yale.
- 12:21Speaker 4: And over the past twenty five years there have been
- 12:24Speaker 4: one hundred more more than one hundred studies published on
- 12:27Speaker 4: catamene for depression, anxiety, PTSD, OCD, ANAREXCA I mean any
- 12:31Speaker 4: number of mental health issues. And this is done in
- 12:35Speaker 4: a much lower dose than in an anesthetic context. So
- 12:39Speaker 4: what you're talking about is about ten percent of the
- 12:42Speaker 4: dose you might use in a physical medical procedure. You're
- 12:45Speaker 4: using a tiny fraction of that. So you stay awake,
- 12:48Speaker 4: you're conscious when you're having the experience, but it does
- 12:51Speaker 4: alter your consciousness a little bit, and I can.
- 12:53Speaker 3: Tell you a little how that actually feels when you're
- 12:55Speaker 3: doing it.
- 12:58Speaker 2: So, okay, so that's what is talk about your experience.
- 13:02Speaker 4: Yeah, particularly so I'll give you the kind of I'll
- 13:06Speaker 4: give you both the how it set up and how
- 13:09Speaker 4: it actually feels. Because when Kennymine was used for anesthesia,
- 13:14Speaker 4: it was administered intravenously that you know, in a hospital setting,
- 13:17Speaker 4: you'd get an IV during a procedure. And when it
- 13:20Speaker 4: was discovered that Kenymine could help with mental health, it
- 13:25Speaker 4: was kind of done the same way doctors would administer
- 13:27Speaker 4: an IV. And that's really effective. But the problem is
- 13:30Speaker 4: it's pretty expensive and it's not that accessible. You had
- 13:33Speaker 4: to basically have a few hours to go sit in
- 13:35Speaker 4: a clinic if you were lucky enough to live near one,
- 13:38Speaker 4: and the price was often about a thousand dollars a session,
- 13:41Speaker 4: and so you had to be lucky enough to live
- 13:43Speaker 4: near a clinic to have the time to go sit
- 13:45Speaker 4: there for a few hours and have the money to
- 13:48Speaker 4: afford it. And what mind Bloom set out to do
- 13:52Speaker 4: was actually make that way more accessible and affordable for regular,
- 13:55Speaker 4: everyday folks. And so the way we operate, I can
- 13:57Speaker 4: tell you more about this later, is we do at
- 14:00Speaker 4: home ketamine therapy with sublingual tablets, and so there's no
- 14:04Speaker 4: IV we.
- 14:05Speaker 3: Have this sublingual tablet.
- 14:06Speaker 4: And when I was a client before I actually worked here,
- 14:09Speaker 4: so I was doing my sessions in my apartment in
- 14:12Speaker 4: New York City. Medicines delivered to your door, along with
- 14:16Speaker 4: a journal and imass blood pressure, cough, heart rate monitor,
- 14:19Speaker 4: things like this to kind of just help with the treatment.
- 14:22Speaker 4: You have a guide who is a coach of sorts
- 14:27Speaker 4: to really support you throughout the treatment. But when you
- 14:30Speaker 4: take the medicine, you're basically taking it under your tongue,
- 14:33Speaker 4: putting on an imask in headphones, and turning inward. And
- 14:36Speaker 4: so I can tell you a little bit more later
- 14:37Speaker 4: about the whole program itself, but I want to tell
- 14:39Speaker 4: you the experience. The first time I did it, guy,
- 14:44Speaker 4: it was like noise canceling headphones for my brain. It
- 14:48Speaker 4: was like I don't know if you've ever done this.
- 14:50Speaker 4: I had this great pair of bos headphones and you
- 14:52Speaker 4: would click them on and would go whoosh, and it
- 14:56Speaker 4: was like being in the woods when they're full of
- 14:59Speaker 4: snow and damp.
- 15:00Speaker 3: Is all the sound. But that's your thoughts, right, everything just.
- 15:04Speaker 4: And I you immediately realize the contrast, right, You're like,
- 15:07Speaker 4: oh my gosh. I normally have eight thousand thoughts rotating
- 15:12Speaker 4: around per second, and that's kind of my anxiety, my rubidation.
- 15:15Speaker 4: I'm always how do I look? How do I feel?
- 15:17Speaker 4: Am I standing right? What is this thing done? Am
- 15:19Speaker 4: I going to miss this deadline?
- 15:21Speaker 2: You know?
- 15:21Speaker 4: I'm an erotic lawyer, Like it's how it's how we're
- 15:24Speaker 4: we're programmed. A lot of us have those two yeah,
- 15:27Speaker 4: But all of a sudden, and I could have one
- 15:30Speaker 4: thought or no thoughts at a time.
- 15:33Speaker 3: I'd just be and I.
- 15:35Speaker 4: Had this sensation. I had this feeling. I'm getting chills
- 15:38Speaker 4: thinking about it. I was in an igloo. I think
- 15:44Speaker 4: the igloo is important because it's cold in an igloo
- 15:46Speaker 4: and sweating.
- 15:46Speaker 3: And heat rois part of my thing.
- 15:49Speaker 4: But I'm in this igloo and in it there are doors,
- 15:56Speaker 4: and each of the doors leads to a different situation
- 16:01Speaker 4: that fills me with anxiety. And so that might be
- 16:05Speaker 4: a date or a presentation or job interview, whatever it is, and.
- 16:11Speaker 3: I could be in that setting.
- 16:12Speaker 4: I could be in the physical place experiencing what was happening,
- 16:16Speaker 4: but not with.
- 16:17Speaker 3: The same physical sensations.
- 16:18Speaker 4: I didn't have the type chest, I didn't have the sweating,
- 16:20Speaker 4: I didn't have all that stuff. And it was the
- 16:23Speaker 4: first time I realized that those weren't inextricably linked, that
- 16:28Speaker 4: you just because you had the trigger didn't mean you
- 16:30Speaker 4: had to have the response. And so I would spend
- 16:35Speaker 4: time in one room and I would go out and
- 16:36Speaker 4: spend time in the next and just experience being in
- 16:39Speaker 4: these settings not feeling that way, and it was unbelievably powerful.
- 16:44Speaker 3: And I was there for a bit.
- 16:47Speaker 4: You know, you feel the medicine for about an hour,
- 16:49Speaker 4: and then you come back to baseline and you journal
- 16:53Speaker 4: for a little bit, and then you get back on
- 16:55Speaker 4: zoom with your guide and talk about it. But for me,
- 16:57Speaker 4: it was like that holy cow moment. It was just
- 17:01Speaker 4: like this is different. And so for me, Step one
- 17:05Speaker 4: was really working on that anxiety. And once I worked
- 17:07Speaker 4: on that for a while, then it was like, well,
- 17:09Speaker 4: what else do I want to work on? And it
- 17:10Speaker 4: was really meaning and purpose. It was what am I doing?
- 17:13Speaker 3: Is this right?
- 17:14Speaker 4: Is this how I want to devote my energy, my
- 17:17Speaker 4: my value to the world in my career? And the
- 17:20Speaker 4: answer was no. And that's why I went from client
- 17:22Speaker 4: to employee.
- 17:23Speaker 3: Here.
- 17:25Speaker 1: That's incredible, that's inspiring. I mean that experience is really
- 17:28Speaker 1: what in a sense, a certain form of trauma healing
- 17:33Speaker 1: is like understanding that the trigger is not happening right
- 17:37Speaker 1: now now? Was that something that was that an.
- 17:40Speaker 2: Intention for you? Before you did this? You setting a
- 17:44Speaker 2: touch on.
- 17:44Speaker 4: My anxiety, But I didn't really have more specifics than that.
- 17:49Speaker 4: It was because I didn't know, you know, I didn't
- 17:52Speaker 4: know what to expect. And I think, you know, looking
- 17:55Speaker 4: back on it now, I think there's this odd thing
- 18:00Speaker 4: that happens with psychedelics where it kind of gives you
- 18:04Speaker 4: what you need, but it's not always what you thought
- 18:07Speaker 4: you needed going in.
- 18:08Speaker 3: And I think, you know, one of.
- 18:11Speaker 4: My lessons for mental health is like, we're not very
- 18:14Speaker 4: good at predicting things. We overestimate our ability to predict things.
- 18:18Speaker 4: We often overestimate how much other people are thinking about us,
- 18:22Speaker 4: or how much they care about what we're doing. We overestimate,
- 18:26Speaker 4: you know, how big of a problem something might be
- 18:28Speaker 4: in our lives, but we also might overestimate our ability
- 18:31Speaker 4: to like fix ourselves and heal ourselves. And I think
- 18:33Speaker 4: sometimes what you have to do with psychedelics is just
- 18:36Speaker 4: surrendered to the medicine and not necessarily say I'm going
- 18:39Speaker 4: to go in and think about this for the whole time,
- 18:41Speaker 4: or I'm going to solve this problem. You kind of
- 18:43Speaker 4: go in with something broader that says like I would
- 18:47Speaker 4: like to be free from this social anxiety, and then
- 18:52Speaker 4: in the session, rather than holding really tightly to that thought,
- 18:56Speaker 4: you set the intention and then you kind of release
- 18:58Speaker 4: it and you see what comes up. And sometimes it
- 19:00Speaker 4: might be that sometimes it might be an older trauma
- 19:03Speaker 4: or memory or something else. But usually I find that
- 19:06Speaker 4: something in your brain cues up the thing that you need.
- 19:09Speaker 3: To work on.
- 19:11Speaker 1: So let's talk more specifically about mind bloom, Yeah, what
- 19:15Speaker 1: it is.
- 19:18Speaker 2: And who it's for.
- 19:19Speaker 3: Yeah.
- 19:21Speaker 4: Ultimately this is at home psychedelic therapy. We are trying
- 19:26Speaker 4: to make this treatment, starting with ketamine therapy, more accessible, affordable,
- 19:33Speaker 4: and approachable for people in need. And so when we
- 19:35Speaker 4: talk about people in need. I mean, it's almost become
- 19:39Speaker 4: a cliche that we're in a mental health crisis, but
- 19:42Speaker 4: I think the stat's bear repeating is you know, last year,
- 19:47Speaker 4: fifty five thousand Americans committed suicide, two million attempted it,
- 19:53Speaker 4: one hundred and ten thousand.
- 19:55Speaker 3: Died of drug overdoses.
- 19:56Speaker 4: There are forty seven million Americans taking as anti depressants
- 20:01Speaker 4: this year.
- 20:02Speaker 3: I mean, those are.
- 20:03Speaker 4: Staggering numbers, right, And when you look at the first
- 20:07Speaker 4: line treatments, you know, the first line treatments are ssri
- 20:11Speaker 4: or you know, anti depressant pills.
- 20:13Speaker 3: What we think of was like prozac.
- 20:16Speaker 4: And psychotherapy, and those help a lot of people, they
- 20:19Speaker 4: really do, you know, I want to be clear that
- 20:21Speaker 4: those medicines have helped. Those medicines and psychotherapy have helped
- 20:24Speaker 4: millions of people, but they don't help everyone. If they did,
- 20:28Speaker 4: we wouldn't be in this mental health crisis. If those
- 20:30Speaker 4: treatments were all you needed to feel better, the country
- 20:34Speaker 4: would look different right now. But instead you have people
- 20:37Speaker 4: that are really suffering. And what we see so often
- 20:40Speaker 4: as people who kind of bounce back and forth from
- 20:42Speaker 4: one treatment to another, hoping something works and maybe they
- 20:45Speaker 4: get relief for a bit maybe they don't, and psychedelic
- 20:50Speaker 4: medicine really offers something different. I think it offers a
- 20:52Speaker 4: way to address the root causes of suffering by not
- 20:58Speaker 4: just kind of adjusting chemical in the brain that mask symptoms,
- 21:03Speaker 4: but helping us really get to the bottom of what's
- 21:06Speaker 4: causing us depression or anxiety or sadness, grief, whatever that
- 21:10Speaker 4: thing is, you know, getting to understand our trauma and
- 21:12Speaker 4: how our trauma affects us today and actually like work
- 21:15Speaker 4: past it or resolve those issues in our heads. And so,
- 21:18Speaker 4: you know, I think what we're really trying to do
- 21:22Speaker 4: is give people a chance to really heal. And you know,
- 21:30Speaker 4: we started with ketamine therapy because it's the only psychedelic
- 21:35Speaker 4: that's legal today. And this is kind of heartbreaking because
- 21:40Speaker 4: we have this crisis. I mean, I just shared these numbers.
- 21:44Speaker 4: You know. The other number that I have a hard
- 21:46Speaker 4: time wrapping my head around is that twenty two veterans
- 21:48Speaker 4: commit suicide every single day, and most of those are
- 21:52Speaker 4: people with PTSD from their service.
- 21:55Speaker 3: And when you.
- 22:00Speaker 4: Work with psychedelics, they really work in two ways. There's
- 22:05Speaker 4: kind of a chemical level and then there's also a
- 22:07Speaker 4: conscious level. And I think the conscious levels it's undersold
- 22:12Speaker 4: in some ways. You know, there are some researchers out
- 22:14Speaker 4: there who say, oh, it's just the chemical thing, the
- 22:16Speaker 4: trip doesn't matter, And I think anybody who's really worked
- 22:20Speaker 4: with these medicines knows that's not true, because yes, there
- 22:24Speaker 4: is something that happens in your brain, and I can
- 22:25Speaker 4: talk about what that is with ken mean, but for me,
- 22:27Speaker 4: I think that the healing experience of revisiting some of
- 22:30Speaker 4: these memories, understanding things, and having the support to actually
- 22:33Speaker 4: work through them is what lets you not just address
- 22:35Speaker 4: symptoms but actually like get past these issues. And so,
- 22:40Speaker 4: you know, talking about the scope of this problem and
- 22:43Speaker 4: the psychedelics that aren't legal today, I mean MDMA therapy, right,
- 22:47Speaker 4: people think of MDMA as ecstasy party drug. It's the
- 22:51Speaker 4: most effective PTSD treatment that's ever been studied. So the
- 22:57Speaker 4: trials that were presented to the FDA this year showed
- 23:01Speaker 4: that if people with PTSD who got MDMA assistant therapy
- 23:06Speaker 4: and that's MDMA with psychotherapy after only three medicine sessions
- 23:10Speaker 4: and twelve psychotherapy sessions, eighty seven percent of patients has
- 23:16Speaker 4: significant improvements and sixty seven percent no.
- 23:19Speaker 3: Longer met the criteria for PTSD.
- 23:21Speaker 4: They were essentially few, and as anyone who's worked in
- 23:25Speaker 4: the field knows, those numbers are bretting. But it's illegal,
- 23:29Speaker 4: and it's illegal because of decades of overregulation and stigma attached.
- 23:33Speaker 4: And so we started with kettemine therapy first because it's legal,
- 23:37Speaker 4: but second because it is incredibly effective and.
- 23:41Speaker 3: Safe to use. I mean, we've.
- 23:43Speaker 4: Seen not just with our programs but with all the
- 23:45Speaker 4: research out there that it's incredibly effective and fast acting
- 23:49Speaker 4: and side effects are incredibly rare.
- 23:51Speaker 3: In our study, about five percent of people experienced them
- 23:53Speaker 3: side effect, and.
- 23:54Speaker 4: So it's a really safe and effective and fast acting
- 23:57Speaker 4: medicine's use. You know, the way it works is so
- 24:02Speaker 4: interesting because there's this chemical effect. You know, it works
- 24:06Speaker 4: on the default mode network, which is the part of
- 24:09Speaker 4: the brain that kind of is self referential and regulating
- 24:13Speaker 4: kind of how am I doing, how am I looking, how.
- 24:15Speaker 3: Am I feeling? Kind of that's where a lot of
- 24:16Speaker 3: rumination happens, and it quiets that down.
- 24:19Speaker 4: I only learned this after I took it, but my
- 24:20Speaker 4: experience of kind of the noise canceling headphones like that
- 24:23Speaker 4: has a real basis in the brain, and it also
- 24:27Speaker 4: stimulates the production of something called brain derived neurotrophic factor BDNF.
- 24:31Speaker 3: They call that fertilizer for the brain.
- 24:34Speaker 4: And what the studies show is that in people with
- 24:36Speaker 4: chronic depression, the neural connections the signaling in the brain
- 24:41Speaker 4: in the areas associated with mood and emotional regulation, those
- 24:45Speaker 4: connections are damaged. There are fewer of them, they're weaker,
- 24:48Speaker 4: they break apart, and when you stimulate production in BDNF,
- 24:52Speaker 4: you actually regrow those neural connections.
- 24:54Speaker 3: You actually are rewiring your brain.
- 24:57Speaker 4: And other psychedelics do that too, but their work at
- 25:00Speaker 4: this incredible level to quiet some of that rumination and
- 25:02Speaker 4: actually let you grow the neural connections you need to
- 25:06Speaker 4: think and feel better. And then it gives you that
- 25:09Speaker 4: psychedelic experience of actually altering your consciousness, your perception, and
- 25:14Speaker 4: viewing your life or your memories through a different lens
- 25:17Speaker 4: that could be so powerful for healings. So it's an
- 25:19Speaker 4: absolutely incredible medicine.
- 25:22Speaker 2: Who are some of the people that this is not for?
- 25:27Speaker 4: Yeah, sorry you asked that question, and I kind of
- 25:29Speaker 4: went off on a tangent there. In terms of who
- 25:32Speaker 4: it's for. We currently treat people with depression, anxiety and PTSD.
- 25:37Speaker 4: There are other studies of you know INAREXI and OCD,
- 25:40Speaker 4: which I mentioned. I think those are areas we're really
- 25:43Speaker 4: curious about, but do not currently offer treatment for those
- 25:46Speaker 4: directly today.
- 25:47Speaker 3: The people it's not for, I'll mentioned a few things.
- 25:51Speaker 4: You know. First off, everyone should work with a psychiatric
- 25:55Speaker 4: clinician to use this medicine. You know, mind Bloom works
- 25:58Speaker 4: with psychiatrists, practitioners, and physician assistants who do the clinical evaluation, prescribing, treatment, etc.
- 26:06Speaker 3: It's really important not to try to do this on
- 26:07Speaker 3: your own.
- 26:08Speaker 4: And they have a list of criteria that they use
- 26:11Speaker 4: to evaluate, you know, who's a good candidate, who's.
- 26:13Speaker 3: Not some people who might not be.
- 26:16Speaker 4: If you have certain free existing conditions, certain heart conditions,
- 26:19Speaker 4: certain respiratory conditions can make you a poor candidate.
- 26:23Speaker 3: Substance use is interesting.
- 26:25Speaker 4: They don't interact with medicines like SSRIs ketemine doesn't, so
- 26:29Speaker 4: you can keep taking other mental health medications. But if
- 26:33Speaker 4: you have severe substance addiction, maybe you know, taking a.
- 26:38Speaker 3: Mind altering substance might not be appropriate.
- 26:40Speaker 4: But it really depends because the studies have also shown
- 26:42Speaker 4: it can be really effective in substance use disorder, and
- 26:46Speaker 4: so it's kind of a paradox. If you're working with
- 26:48Speaker 4: the right clinician and you're doing it, you know, in
- 26:50Speaker 4: part to help those substance issues, it can be really helpful,
- 26:53Speaker 4: but it may not be appropriate if you haven't started
- 26:56Speaker 4: to work on your substance use and if that's not
- 26:57Speaker 4: what you're there for. And with trauma, I think it
- 27:02Speaker 4: can be really helpful for people with you know, serious trauma,
- 27:05Speaker 4: but you need to have the right support in place.
- 27:07Speaker 3: And so this is where I think the type of
- 27:10Speaker 3: program really matters.
- 27:12Speaker 4: There are some Keemine therapy programs that are basically medicine only.
- 27:16Speaker 4: You get you know, the IV or you get a pill,
- 27:19Speaker 4: and that's kind of the treatment.
- 27:22Speaker 3: What ours does is different.
- 27:23Speaker 4: It's medicine plus coaching, content and community. What that means
- 27:28Speaker 4: is you have the medicine, you have coaching not just
- 27:31Speaker 4: from your clinician, but from a guide who's there to
- 27:33Speaker 4: meet with you before and after your sessions to help
- 27:36Speaker 4: you prepare for the session, integrate the experience afterwards, Recommend
- 27:40Speaker 4: meditations or exercises, things you can do really help you
- 27:43Speaker 4: unpack the experience.
- 27:45Speaker 3: The content is stuff you do in our mobile app.
- 27:48Speaker 4: It's audio for the session, but also journaling and other exercises.
- 27:51Speaker 3: In between and the community. We have these group integration
- 27:55Speaker 3: circles where people who are going through treatment can meet
- 27:58Speaker 3: with others and share their experiences, you know, psychedelics. It's
- 28:01Speaker 3: like seeing a new color.
- 28:02Speaker 4: Once you see it, you're like, oh my god, I
- 28:04Speaker 4: want to tell people about this, But if nobody else
- 28:06Speaker 4: has seeing the color, they're going to be like, whatever, dude,
- 28:08Speaker 4: new color. So having other people who are doing it
- 28:11Speaker 4: also is really valuable. And I think having that support,
- 28:14Speaker 4: having the coach and having the community is what let's
- 28:17Speaker 4: especially people with kind of more severe trauma, do it
- 28:20Speaker 4: in a really you know, in a way that's safe
- 28:22Speaker 4: and conduce it to healing.
- 28:24Speaker 1: So prior to the actual taking of the medicine, how
- 28:31Speaker 1: many meetings are there and lead up to it.
- 28:34Speaker 4: So you come to our website and you can fill
- 28:37Speaker 4: out an initial survey with some threshold questions about, you know,
- 28:40Speaker 4: what you're experiencing.
- 28:41Speaker 3: Is this right for you?
- 28:43Speaker 4: If it is, you can sign up to have a
- 28:45Speaker 4: consultation with a clinician, which is between forty five and
- 28:47Speaker 4: sixty minutes, and that's kind of like any normal, you know,
- 28:51Speaker 4: psychiatrist visit. You're doing a medical history and evaluation, what
- 28:54Speaker 4: are you experiencing for how long, what are your symptoms?
- 28:57Speaker 4: All that, and if treatment is appropriate, they will submit
- 29:02Speaker 4: a prescription that's.
- 29:02Speaker 3: Sent to your home.
- 29:04Speaker 4: Before that first session, you get on zoom with your guide,
- 29:08Speaker 4: and you also have a pure treatment monitor who's home
- 29:11Speaker 4: with you. That's usually a friend or family member, someone
- 29:14Speaker 4: who's home with you during the treatment session. And that
- 29:17Speaker 4: person's really there to create a comfortable environment. You know,
- 29:21Speaker 4: it's not I personally don't think of it as a
- 29:24Speaker 4: safety thing. I think of it as like someone the
- 29:26Speaker 4: doorbell rings, the phone rings. Maybe you want, you know,
- 29:28Speaker 4: someone to walk you to the bathroom and get you
- 29:30Speaker 4: a glass of water or whatever it is.
- 29:31Speaker 3: It's really like, let me be comfortable and.
- 29:33Speaker 4: Let go in this session rather than having to think
- 29:36Speaker 4: about the house or the dog.
- 29:37Speaker 3: Or whatever else is going on.
- 29:39Speaker 4: So before that first session, you've met with your clinician
- 29:42Speaker 4: already and now you are meeting on the zoom with
- 29:44Speaker 4: your guide and that could be thirty to sixty minutes
- 29:47Speaker 4: and it's really you know, basically like going over how
- 29:50Speaker 4: to take the medicine, what to expect, but also preparing
- 29:54Speaker 4: and setting intentions and so an intention is kind of
- 29:57Speaker 4: like what I described before, where you're you know, you're
- 30:01Speaker 4: not rigidly holding onto some goal something specific, but you know,
- 30:04Speaker 4: I want to relate better to my mom or I
- 30:07Speaker 4: want to let go of my social anxiety, and you
- 30:09Speaker 4: kind of set an intention that guides are journey and
- 30:12Speaker 4: so that Zoom session takes place right before the session,
- 30:16Speaker 4: you take the medicine. At about ninety minutes later, you
- 30:18Speaker 4: get back on Zoom with your guide to start unpacking it.
- 30:22Speaker 2: Very cool.
- 30:23Speaker 1: Now let's talk about what I feel a lot of
- 30:27Speaker 1: people might have concerns about.
- 30:28Speaker 2: Is this is not regulated.
- 30:33Speaker 1: Some might say it's a wild West of psychedelics. Right,
- 30:37Speaker 1: we don't know exactly what's going to happen. Yeah, things
- 30:41Speaker 1: do happen. Where does all that fit in? What do
- 30:47Speaker 1: you say?
- 30:48Speaker 3: Yeah, I mean it's a great question, guy.
- 30:50Speaker 4: I mean, if you read the news, there are a
- 30:53Speaker 4: lot of stories out there that speak negatively of ketamine
- 30:58Speaker 4: and other psychedelics.
- 30:58Speaker 3: Their frameman is dangerous or untested or unproven.
- 31:04Speaker 4: The science says otherwise, the science is really clear that
- 31:09Speaker 4: ketamine is safe and effective and fast acting, and other
- 31:14Speaker 4: psychedelics are coming along and kind of building evidence to
- 31:16Speaker 4: get to that level.
- 31:17Speaker 3: But let's talk about ketemine. It is regulated, maybe more
- 31:22Speaker 3: than people think.
- 31:24Speaker 4: You know, it is prescribed by doctors and nurses and
- 31:27Speaker 4: pas who are regulated by medical boards and nursing boards,
- 31:32Speaker 4: and they sometimes set guidelines around ketamine therapy and other treatments.
- 31:36Speaker 4: They certainly can review prescriptions and prescribing practices and treatment
- 31:41Speaker 4: plans and all those things.
- 31:43Speaker 3: You know.
- 31:43Speaker 4: The DEA does regulate the prescription of controlled substances. They
- 31:47Speaker 4: keep tabs on where prescriptions are going out. Providers have
- 31:50Speaker 4: to register with them.
- 31:52Speaker 3: You know.
- 31:52Speaker 4: The FDA regulates how medicines are manufactured and marketed, and
- 31:58Speaker 4: so I think there's actually more regulation of this of
- 32:01Speaker 4: kennemine therapy specifically than some people might think.
- 32:04Speaker 3: I think when people describe the wild.
- 32:08Speaker 4: West, I think some of where that comes from is
- 32:14Speaker 4: that there's not just one way to do ketemine therapy.
- 32:17Speaker 3: You know, usually when something is approved.
- 32:19Speaker 4: By the FDA, they there's one way. Okay, it's this dose,
- 32:24Speaker 4: it's this amount. You know, you take fifty milligrams for
- 32:26Speaker 4: this one hundred million into Kenymine can be done through
- 32:31Speaker 4: IV and a clinic. It can be done through tablets
- 32:34Speaker 4: at home or a nasal spray or an oral you know,
- 32:37Speaker 4: it's it's kind of evolved through different paths and with
- 32:41Speaker 4: different ways of providing it. So again there's medicine only
- 32:44Speaker 4: you can do it with psychotherapy, you can do it
- 32:46Speaker 4: with coaching like we do.
- 32:48Speaker 3: You know, there's just there's.
- 32:50Speaker 4: Enough variety in it that I think people say, oh,
- 32:53Speaker 4: you know, how do I get my arms around this?
- 32:54Speaker 4: How do I know what's the right way to do
- 32:57Speaker 4: it and what's the wrong way to do it? And
- 33:00Speaker 4: my antique to that is usually, let's look at the evidence.
- 33:02Speaker 3: And so when it comes to.
- 33:03Speaker 4: Mind bloom, we've actually provided our treatment data to independent
- 33:10Speaker 4: researchers and published the two largest studies in the history
- 33:13Speaker 4: of ketemine therapy. The first one was the largest ever
- 33:16Speaker 4: with I think it was one two hundred and forty
- 33:19Speaker 4: seven patients, and then the second one was almost ten
- 33:24Speaker 4: times larger at eleven thousand and four forty seven patients,
- 33:27Speaker 4: And that over that sample size, what you saw, you know,
- 33:31Speaker 4: is that sixty three percent of clients have really significant
- 33:35Speaker 4: improvements and symptoms, eighty nine percent have some improvement overall,
- 33:39Speaker 4: and less than five percent are reporting any side effects,
- 33:42Speaker 4: which usually are really short lived.
- 33:43Speaker 3: In mild, maybe headachere nausea.
- 33:45Speaker 4: But you know, we've now built up so much data
- 33:49Speaker 4: that we can confidently say at home kenemene therapy when
- 33:52Speaker 4: done in this way with medicine plus coaching content community,
- 33:56Speaker 4: is really.
- 33:56Speaker 3: Helping people and it's really safe. And it's really sad
- 34:01Speaker 3: to me when I see some of these headlines out there.
- 34:03Speaker 3: And I'll give you a specific example. You may be
- 34:08Speaker 3: familiar with.
- 34:09Speaker 4: Matthew Perry's death last year, and ketamine played a role
- 34:12Speaker 4: in his death. And you know that was a situation
- 34:19Speaker 4: where he took insane amounts, massive amounts of recreational ketamine
- 34:26Speaker 4: that he got illegally and then went to the hot tub.
- 34:29Speaker 4: He was also taking opiates and drinking alcohol. And that's
- 34:34Speaker 4: a tragedy. His death is a tragedy, but it's not
- 34:37Speaker 4: to say that someone took medically supervised ketamine in an
- 34:41Speaker 4: appropriate dose and had a bad outcome. And so you know,
- 34:45Speaker 4: when I look at the big picture with this mental
- 34:47Speaker 4: health crisis, there are five hundred people that die every
- 34:50Speaker 4: year from taking too much tailano. I'm not aware of
- 34:53Speaker 4: anyone anyone who has died from taking too much ketamine.
- 34:58Speaker 3: It's really when people drugs and misuse things.
- 35:01Speaker 4: And so to me, the really important thing is working
- 35:05Speaker 4: with good providers, taking the medicine as directed, just like
- 35:08Speaker 4: anything else, just like tie it all, and following a
- 35:11Speaker 4: treatment program that's established and has been shown to be
- 35:13Speaker 4: safe and effective, and taking this seriously like any treatment,
- 35:16Speaker 4: you know. I mean, I think the sad truth is
- 35:20Speaker 4: people are really struggling and looking for ways to self medicate.
- 35:23Speaker 4: But the people who know best are the providers who
- 35:25Speaker 4: are trained in this, who have gone to school, and
- 35:27Speaker 4: who have worked for decades to learn how to do
- 35:30Speaker 4: this safely and effectively.
- 35:33Speaker 1: I love what you're saying about the content community and coaching.
- 35:37Speaker 1: The community part to me really stands out. I think
- 35:41Speaker 1: it's going to kind of resonate with a lot of
- 35:43Speaker 1: our listeners. All Right, So how do people learn more
- 35:47Speaker 1: about what you're doing? And maybe if they're interested in
- 35:51Speaker 1: moving forward with this, where do they go?
- 35:53Speaker 4: Yeah, the best way to do it is to come
- 35:55Speaker 4: to mind bloom dot com. That's DLM. We have a
- 36:02Speaker 4: bunch of information on the website about what ketamine is,
- 36:06Speaker 4: how it works. We have different pathways for issues, whether
- 36:09Speaker 4: it's grief or anxiety or more nuanced things like burnout,
- 36:13Speaker 4: or getting unstuck.
- 36:16Speaker 3: We have safety information.
- 36:18Speaker 4: We have a blog where we post all kinds of information,
- 36:22Speaker 4: not just about ketemine therapy but other psychedelics. And it's
- 36:25Speaker 4: also where people can take that initial survey and sign up.
- 36:29Speaker 1: Okay, we'll have that link up here at the show
- 36:31Speaker 1: notes page at the Trauma Therapists podcast dot com. Mike,
- 36:36Speaker 1: super inspiring, and I really appreciate you sharing your own story.
- 36:41Speaker 1: I think that helps people understand your journey and how
- 36:45Speaker 1: the heck you got into this well, not.
- 36:47Speaker 3: Just that guy.
- 36:48Speaker 4: I hope it helps them understand how, you know, ketemine
- 36:51Speaker 4: therapy and psychedelic medicine can help them too. You know,
- 36:54Speaker 4: I was one of those people who said, well, this
- 36:58Speaker 4: is just my life, this is what this is. My
- 37:00Speaker 4: destiny is to struggle with this forever. This is my
- 37:02Speaker 4: cross to bear, whatever you want to say, because I've
- 37:06Speaker 4: tried these treatments for twenty years and nothing worked, you know,
- 37:09Speaker 4: and then something did, and if nothing else, I want
- 37:13Speaker 4: people to know that, you know, maybe this can work
- 37:15Speaker 4: for them too, that this is different from the other
- 37:18Speaker 4: medicines they've tried, of the other things they've done to
- 37:20Speaker 4: try to improve their mental health. This is different, it's unique,
- 37:23Speaker 4: and it's incredibly effective and it can work for them too,
- 37:27Speaker 4: if they have the right providers, the.
- 37:30Speaker 3: Right team behind them, and the support of a comprehensive program.
- 37:34Speaker 2: Awesome all Mike will be in touch. Thanks so much
- 37:36Speaker 2: for being here.
- 37:37Speaker 3: Thank you guy, I really appreciate it, though had to
- 38:04Speaker 3: come to s